Cargando…
Exploration of Flavonoids as Lead Compounds against Ewing Sarcoma through Molecular Docking, Pharmacogenomics Analysis, and Molecular Dynamics Simulations
Ewing sarcoma (ES) is a highly malignant carcinoma prevalent in children and most frequent in the second decade of life. It mostly occurs due to t(11;22) (q24;q12) translocation. This translocation encodes the oncogenic fusion protein EWS/FLI (Friend leukemia integration 1 transcription factor), whi...
Autores principales: | Yasir, Muhammad, Park, Jinyoung, Han, Eun-Taek, Park, Won Sun, Han, Jin-Hee, Kwon, Yong-Soo, Lee, Hee-Jae, Hassan, Mubashir, Kloczkowski, Andrzej, Chun, Wanjoo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9823950/ https://www.ncbi.nlm.nih.gov/pubmed/36615603 http://dx.doi.org/10.3390/molecules28010414 |
Ejemplares similares
-
Investigation of Flavonoid Scaffolds as DAX1 Inhibitors against Ewing Sarcoma through Pharmacoinformatic and Dynamic Simulation Studies
por: Yasir, Muhammad, et al.
Publicado: (2023) -
Exploration of Potential Ewing Sarcoma Drugs from
FDA-Approved Pharmaceuticals through Computational Drug Repositioning,
Pharmacogenomics, Molecular Docking, and MD Simulation Studies
por: Hassan, Mubashir, et al.
Publicado: (2022) -
Computational Exploration of Licorice for Lead Compounds against Plasmodium vivax Duffy Binding Protein Utilizing Molecular Docking and Molecular Dynamic Simulation
por: Yasir, Muhammad, et al.
Publicado: (2023) -
Oncomeric Profiles of microRNAs as New Therapeutic Targets for Treatment of Ewing’s Sarcoma: A Composite Review
por: Hassan, Mubashir, et al.
Publicado: (2023) -
EWS/FLI1 Characterization, Activation, Repression, Target Genes and Therapeutic Opportunities in Ewing Sarcoma
por: Yasir, Muhammad, et al.
Publicado: (2023)